Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB1 | P20618 | 4/20 | 0.49 |
| ▸ | PSMB5 | P28074 | 4/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 10/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | PSMB2 | P49721 | 3/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7778580 | 0.90 | LTA4H (0.53) | PSMB1PSMB5LTA4HPTGS2PTGS1 | |
| SCHEMBL7108553 | 0.84 | KDM4E (0.49) | PSMB1PSMB5KDM4ELTA4HPTGS2 | |
| SCHEMBL7466056 | 0.83 | LTA4H (0.61) | KDM4ELTA4HALDH1A1HRH3KCNH2 | |
| SCHEMBL7926826 | 0.77 | LTA4H (0.45) | PSMB1PSMB5KDM4ELTA4HPTGS2 | |
| SCHEMBL7918786 | 0.76 | LTA4H (0.47) | PSMB1PSMB5KDM4ELTA4HPTGS2 | |
| SCHEMBL7469979 | 0.75 | LTA4H (0.51) | PSMB1PSMB5KDM4ELTA4HHRH3 | |
| SCHEMBL7650467 | 0.74 | KDM4E (0.57) | PSMB1PSMB5KDM4ELTA4HALDH1A1 | |
| SCHEMBL3130426 | 0.72 | LTA4H (0.52) | PSMB1PSMB5LTA4HPTGS2PTGS1 | |
| SCHEMBL15257179 | 0.71 | LTA4H (0.82) | PSMB1PSMB5KDM4ELTA4HPSMB2 | |
| SCHEMBL14970684 | 0.71 | LTA4H (0.82) | PSMB1PSMB5KDM4ELTA4HPSMB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1357903-A2 | STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4- 2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO b]THIOPHENE AND SALTS THEREOF | ELI LILLY AND COMPANY (US) | 2003-11-05 | — | — | EP | disclosed |
| EP-1204655-A2 | A CRYSTALLINE FORM OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL)ETHOXY] PHENOXY)-2-(4-METHOXYPHENYL)BENZO[B]THIOPHENE HYDROCHLORIDE | ELI LILLY AND COMPANY (US) | 2002-05-15 | — | — | EP | disclosed |
| WO-2001085147-A2 | STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO[b]THIOPHENE AND SALTS THEREOF | ELI LILLY AND COMPANY (US) | 2001-11-15 | — | — | WO | disclosed |
| WO-2001009115-A2 | A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1- YL)ETHOXY] PHENOXY)-2- (4-METHOXYPHENYL) BENZO[b]THIOPHENE HYDROCHLORIDE | ELI LILLY AND COMPANY (US) | 2001-02-08 | — | — | WO | disclosed |